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Summary
Background:  Left  atrial  appendage  (LAA)  thrombus  increases  the  risk  of  thromboembolism  in
atrial ﬁbrillation  (AF),  and  LAA  contractile  function  like  emptying  fraction  (EF)  should  have  phys-
iological importance  in  thrombus  formation.  The  aim  of  this  study  was  to  validate  a  velocity
vector imaging  (VVI)  method  for  quantiﬁcation  of  the  LAA  function  and  to  elucidate  echocar-
diographic  parameters  that  are  related  to  the  presence  of  LAA  thrombus  in  patients  with
nonvalvular AF.
Methods:  We  measured  left  atrial  (LA)  dimension  and  LAEF  by  VVI  using  transthoracic  echocar-
diography,  and  LAA  emptying  velocity,  spontaneous  echo  contrast  (SEC),  and  LAAEF  by  VVI  using
transesophageal  echocardiography  (TEE)  in  142  consecutive  patients  with  nonvalvular  AF.  The
wo  groups  according  to  the  presence  (n  =  38)  or  absence  (n  =  104)  ofpatients were  divided  into  t
LAA thrombus.
Results:  There  was  a  good  correlation  between  the  VVI  method  and  manual-tracing  method
for LAAEF  and  LAEF  of  patients  with  AF  (r  =  0.97,  r  =  0.96,  respectively,  p  <  0.001).  LAAEF  in  AF
with thrombus  was  signiﬁcantly  reduced  compared  with  AF  without  thrombus  (16.9  ±  3.1%  and
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330  
29.0  ±  9.7%,  p  <  0.001).  In  multiva
were independent  determinants  
sensitivity  was  92%  and  speciﬁcity
Conclusion:  The  VVI  method  was  
the manual-tracing  method.  LAA
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upresence of  LAA  thrombus.
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trial  ﬁbrillation  (AF)  is  the  most  common  sustained  car-
iac  arrhythmia  associated  with  increased  mortality  and
orbidity  [1—4]. Left  atrial  appendage  (LAA)  thrombus  in
atients  with  AF  is  a  high  risk  factor  for  cardiogenic  cerebral
nfarction.  Echocardiographic  parameters  such  as  LAA  peak
mptying  velocity  (LAAPV)  and  spontaneous  echo  contrast
SEC)  are  proposed  as  important  factors  that  are  related  to
he  presence  of  LAA  thrombus  in  clinical  practice  [5—9].
AA  contractile  function  like  LAA  emptying  fraction  (EF)
nd  LAA  mean  emptying  velocity  (LAAMV)  should  have  a
hysiological  importance  in  LAA  thrombus  formation  [9].
ecently,  a  feature-tracking  echocardiographic  method  has
een  developed  based  on  speckle  tracking  in  which  ultra-
ound  speckles  within  the  image  are  tracked  and  strain  is
etermined  from  the  displacement  of  speckles  in  relation
o  each  other,  therefore  providing  an  angle-independent
arameter  of  cardiac  function  [10—12]. Using  this  method,
ime—LAA  volume  curve  can  be  automatically  and  promptly
rovided.  Thus,  the  evaluation  of  LAA  and  LA  function  by
elocity  vector  imaging  (VVI)  method  is  thought  to  be  useful
n  clinical  practice.  The  aim  of  this  study  was  to  validate
he  LAA  function  parameter  obtained  with  the  VVI-method
y  comparison  with  the  conventional  manual  tracing  method
nd  to  elucidate  echocardiographic  parameters  that  were
elated  to  the  presence  of  LAA  thrombus  in  patients  with
onvalvular  AF.
ethods
tudy  protocol
e  performed  transthoracic  echocardiography  (TTE)  and
ransesophageal  echocardiography  (TEE)  in  171  consecutive
atients  with  Holter  electrocardiographically  documented
hronic  AF  for  more  than  one  month.  There  were  29  AF
atients  excluded  from  the  present  study  because  of  the
xistence  of  mitral  stenosis  or  mild-to-severe  mitral  regurgi-
ation.  We  studied  142  patients  with  nonvalvular  AF  dividing
hem  into  two  groups  according  to  the  presence  (n  =  38)  or
bsence  (n  =  104)  of  LAA  thrombus.  There  were  123  patients
ho  received  an  anticoagulant  drug  (warfarin)  to  avoid
hromboembolism  according  to  CHADS2  score  (congestive
eart  failure,  hypertension,  age  ≥  75  years,  diabetes  melli-
us,  and  prior  stroke  or  transient  ischemic  attack)  [13], when
TE  and  TEE  were  performed.  LAA  thrombus  was  deﬁned  as
n  echo-dense  mass  of  more  than  2  mm  in  diameter  attached
o  the  LAA  wall.  In  addition,  we  studied  36  patients  with
inus  rhythm  to  validate  the  feasibility  and  reliability  of  the
eature-tracking  echocardiographic  method  for  the  quantiﬁ-
ation  of  LAA  and  LA  function.  The  experimental  protocol
S
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riate  logistic  regression  analysis,  LAAEF,  SEC,  and  prior  stroke
of  LAA  thrombus.  Using  20%  of  LAAEF  as  a  cutoff  value,  the
 was  88%  for  LAA  thrombus.
reliable  in  the  measurement  of  LAAEF  and  LAEF  compared  with
EF  assessed  by  the  VVI  method  using  TEE  was  related  to  the
ology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
as  approved  by  the  ethics  committee  of  our  institution  and
nformed  consent  was  obtained  from  all  patients.
chocardiography
TE  and  TEE  were  performed  using  an  ACUSON  sequoia  512
Siemens,  Mountain  View,  CA,  USA)  ultrasound  system  to
alidate  VVI  in  the  quantiﬁcation  of  LAA  and  LA  function.
chocardiographic  parameters  were  obtained  according  to
he  standards  of  the  American  Society  of  Echocardiography
14].  For  TEE,  a  4—7  MHz  multi-plane  transducer  with  a  7.4-
m  diameter  pediatric  probe  was  used  to  diminish  patient
iscomfort:  local  oropharyngeal  anesthesia  with  lidocaine
as  the  only  premedication  as  previously  described  [15].
chocardiographic  images  were  stored  and  transferred  to
 computer  for  off-line  analysis.  LAA  and  LA  volumes  in
atients  with  sinus  rhythm  were  measured  at  the  end  of
trial  diastole  just  before  mitral  valve  opening  (maximal
olume)  and  at  the  end  of  atrial  systole  at  the  onset  of  the  R-
ave  in  the  electrocardiogram  (ECG)  just  after  mitral  valve
losure  (minimal  volume).  The  frame  rate  of  the  TTE  imag-
ng  was  55—60/min  and  that  of  the  TEE  was  60—70/min.  We
easured  LAA  volume  by  two-dimensional  TEE  three  times
t  three  different  angles  from  70◦,  80◦,  and  90◦ and  used
verage  values  for  further  analysis  to  improve  the  accuracy
f  the  LAA  volume  determined  by  VVI.  LAA  and  LA  volumes
n  patients  with  AF  were  measured  during  an  identical  car-
iac  cycle  by  the  conventional  manual-tracing  method  and
y  the  VVI  method  with  the  feature-tracking  echocardiogra-
hy  using  off-line  software  (Syngo  Velocity  Vector  Imaging,
iemens).  The  LAAEF  and  LAEF  were  calculated  from  the
easured  volumes  and  compared  between  the  two  meth-
ds.  With  the  VVI  method,  the  endocardial  border  of  LAA  and
A  is  visually  identiﬁed  by  the  user  and  manually  outlined
t  ﬁrst.  The  manual  placement  of  an  endocardial  tracing
ver  one  frame  is  then  automatically  tracked  throughout
he  cardiac  cycle.  The  software  allows  editing  of  the  initial
race  and  the  endocardial  velocity  is  derived  as  the  ratio
etween  frame-to-frame  displacement  and  the  time  inter-
al  [10—12]. The  velocity  vectors  in  the  two-dimensional
lane  are  displayed  throughout  the  cardiac  cycle,  repre-
enting  displacement  of  the  speckles  in  relation  to  each
ther  along  the  endocardial  contour  of  the  LAA  and  LA
Fig.  1).  The  time—LA  volume  curves  plotted  by  the  speckle-
racking  imaging  method  exhibited  good  agreement  with
hose  determined  using  the  manual  method  [12]. LAAEF
nd  LAEF  were  deﬁned  as  (maximal  volume  −  minimal  vol-
me)/maximal  volume  ×  100%  during  a  cardiac  cycle  using
impson’s  method.  In  addition,  LAAPV,  LAAMV,  SEC  score
grade  0—4),  LA  dimension  (LAD),  and  left  ventricular  (LV)
jection  fraction  were  measured  by  the  same  methods  as
reviously  reported  [5,9,16].  LAAMV  proﬁles  were  obtained
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Figure  1  Representative  image  of  left  atrial  appendage  (LAA)  and  time—volume  curve  constructed  by  velocity  vector  imaging
in patients  with  atrial  ﬁbrillation.  (A)  LAA  of  a  patient  without  thrombus.  Bar  =  1  cm.  (a)  Time—volume  curve  is  shown  (Lower),
time-dv/dt curve  is  shown  (Middle),  and  electrocardiography  is  shown  (Upper).  (B)  Three-dimensional  view  from  a  site  indicated
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Time—volume curve  is  shown  (Lower),  time-dv/dt  curve  is  show
by  pulsed  wave  Doppler  at  the  medial,  mid,  and  lateral  por-
tions  of  the  oriﬁce  and  at  the  deep  mid  portion  of  LAA.
LAAPV  was  measured  at  the  mid  portion  of  the  oriﬁce  of
LAA.  Average  values  of  three  cardiac  cycles  were  analyzed
in  AF.
Reproducibility  and  reliability  of  LAAEF  and  LAEF
by VVI  method
We  determined  interobserver  variability  of  LAAEF  and  LAEF
in  30  randomly  selected  recordings  that  were  measured  by
two  observers  in  a  blinded  way  in  patients  with  sinus  rhythm
and  31  randomly  selected  recordings  that  were  measured  by
two  observers  in  patients  with  AF.  Likewise,  we  determined
intraobserver  variability  of  LAAFE  and  LAEF  in  30  randomly
selected  recordings  that  were  measured  two  times  by  one
observer  in  patients  with  sinus  rhythm,  and  in  31  randomly
selected  recordings  measured  twice  by  one  observer  with  a
7-day  interval  between  the  two  measurements  in  patients
with  AF.
Statistical  analysesData  are  expressed  as  the  mean  ±  one  standard  deviation.
The  relationship  between  VVI  method  and  manual  tracing
method  in  LAAEF  and  LAEF,  and  the  relationship  between
LAAEF  and  LAEF  by  VVI  method  were  tested  by  linear
T
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s)  LAA  of  a  patient  with  thrombus.  *:  thrombus.  Bar  =  1  cm.  (c)
iddle),  and  electrocardiography  is  shown  (Upper).
egression  analysis.  Categorical  data  were  summarized  as
ercentages  and  compared  using  a  Chi-square  test.  Com-
arisons  of  echocardiographic  parameters  between  the  two
roups  were  performed  by  an  unpaired  Student’s  t-test.
omparisons  of  SEC  between  the  two  groups  were  performed
y  Mann—Whitney  U  test.  Comparisons  of  LAAMV  among
he  four  portions  of  the  LAA  were  performed  by  analysis
f  variance  followed  by  post  hoc  testing  with  the  Fisher’s
east  signiﬁcant  difference  test.  The  optimal  cutoff  values
or  the  determination  of  sensitivity  and  speciﬁcity  for  LAA
hrombus  in  echocardiographic  parameters  were  obtained
rom  receiver  operating  characteristic  (ROC)  curve  analy-
is.  Multivariate  logistic  regression  analysis  was  performed
o  identify  the  independent  determinants  of  LAA  thrombus.
 p-value  <  0.05  was  considered  to  be  signiﬁcant.  Statistical
nalyses  were  performed  using  Stat  View  version  5.0  (SAS
nstitute  Inc,  Cary,  NC,  USA).
esults
eproducibility  and  reliability  of  LAAEF  and  LAEF
y VVI  methodhe  interobserver  variability  of  LAAEF  and  LAEF  by  the  VVI
ethod  was  1.8  ±  5.4%  and  0.6  ±  5.4%  in  sinus  rhythm  and
.1  ±  5.7%  and  1.9  ±  4.9%  in  AF,  respectively.  The  interob-
erver  correlation  coefﬁcient  was  0.96  for  LAAEF  and  0.95
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or  LAEF  in  sinus  rhythm  and  0.96  for  LAAEF  and  0.97  for
AEF  in  AF.  The  intraobserver  variability  of  LAAEF  and  LAEF
y  the  VVI  method  was  1.6  ±  4.2%  and  0.6  ±  3.7%  in  sinus
hythm  and  1.0  ±  3.7%  and  1.9  ±  3.9%  in  AF,  respectively.  The
ntraobserver  correlation  coefﬁcient  was  0.98  for  LAAEF  and
.98  for  LAEF  in  sinus  rhythm  and  0.98  for  LAAEF  and  0.97
or  LAEF  in  AF.  It  takes  approximately  1  min  (50  ±  13  s)  to
btain  LAAEF  and  LAEF  by  VVI  method.
atients’  characteristics
he  patients’  clinical  characteristics  are  listed  in  Table  1.
here  were  no  signiﬁcant  differences  in  gender,  history
f  smoking,  history  of  diabetes  mellitus,  history  of  hyper-
ension,  warfarin  therapy,  and  prothrombin-international
ormalized  ratio  (PT-INR)  between  the  AF  group  with  and
ithout  thrombus.  The  averages  of  PT-INR  in  the  two  groups
ere  within  1.6—2.6  that  was  recommended  in  elderly
atients  ≥70  years  old  by  the  Japanese  Circulation  Society.
igniﬁcant  differences  were  observed  in  age,  duration  of  AF,
HADS2  score,  and  prior  stroke.  LAA  thrombus  was  detected
n  38  patients  and  19  thrombi  were  located  deep  in  the  LAA,
8  were  located  at  the  lateral  wall  of  the  LAA  and  4  were
ocated  at  the  medial  wall  of  the  LAA.
chocardiographic  parameters
here  was  a  good  correlation  between  the  VVI  method
nd  manual-tracing  method  for  LAAEF  and  LAEF  of  patients
ith  AF  (r  =  0.97,  r  =  0.96,  respectively,  p  <  0.001)  (Fig.  2).
AAEF  and  LAEF  by  the  VVI  method  for  the  AF  patients
ere  signiﬁcantly  reduced  compared  with  those  in  sinus
hythm  (25.8  ±  10.0%  and  55.9  ±  12.1%,  24.7  ±  7.9%  and
9.6  ±  11.1%,  respectively,  p  <  0.001).  LAAEF  and  LAEF
ssessed  by  the  VVI  method  in  AF  patients  with  thrombus
ere  signiﬁcantly  reduced  compared  with  those  in  AF  with-
ut  thrombus  (16.9  ±  3.1%  and  29.0  ±  9.7%,  18.4  ±  4.3%  and
7.0  ±  8.0%,  respectively,  p  <  0.001)  (Table  2).
LAAMV  in  142  patients  with  AF  varied  signiﬁcantly
mong  the  medial,  mid,  lateral,  and  deep  mid  portions
f  LAA  (26.2  ±  12.3,  21.5  ±  9.8,  15.9  ±  8.4,  19.0  ±  9.2  cm/s,
espectively,  between  deep  and  mid:  p  =  0.045;  except
etween  deep  and  mid:  p  <  0.001)
eterminants  of  LAA  thrombus
ge,  LAEF,  SEC,  LAAPV,  LAAEF,  CHADS2  score,  and  AF
uration  were  tested  in  multivariate  logistic  regression  anal-
sis  as  confounding  factors  (Fig.  3).  Multivariate  logistic
egression  analysis  was  performed  to  identify  the  inde-
endent  determinants  of  LAA  thrombus.  All  variables  with
 p-value  <  0.05  in  an  unpaired  Student’s  t-test  compar-
ng  LAA  thrombus-positive  with  LAA  thrombus-negative
ere  included  in  multivariate  logistic  regression  analy-
is.  However,  LAAMV  was  excluded  because  there  was  a
trong  correlation  between  LAAMV  and  LAAPV  (r  =  0.90, <  0.001).  In  multivariate  logistic  regression  analysis,  LAAEF
p  <  0.001),  SEC  (p  =  0.044),  and  prior  stroke  (p  =  0.038)  were
he  independent  determinants  of  LAA  thrombus  among  the
chocardiographic  parameters  (Table  3).  The  sensitivity,
(
w
d
cM.  Iwama  et  al.
peciﬁcity,  positive  predictive  values,  and  negative  predic-
ive  values  at  the  optimal  cutoff  values  are  listed  in  Table  4.
iscussion
he  present  study  demonstrated  that  LAA  and  LA  function
ould  be  assessed  by  a  VVI  based  on  a  feature-tracking
chocardiographic  method  compared  with  the  traditional
anual-tracing  method.  We  also  showed  that  LAAEF
ssessed  by  the  VVI  method  has  the  feasible  utility  among
he  echocardiographic  parameters  for  thromboembolic  risk
tratiﬁcation.  In  multivariate  logistic  regression  analysis,
AAEF  was  an  independent  determinant  for  LAA  thrombus
mong  the  clinical  and  echocardiographic  parameters.
linical  implications  of  predicting  LAA  thrombus
F  is  the  most  common  sustained  cardiac  arrhythmia
ncountered  in  clinical  practice  with  an  overall  prevalence
f  0.4%  in  the  general  population,  and  increases  with  age
17,18].  Although  guidelines  for  the  management  of  patients
ith  AF  were  established  by  the  committee  of  the  Ameri-
an  College  of  Cardiology,  American  Heart  Association,  and
he  European  Society  of  Cardiology,  thromboembolic  events
elated  to  AF  result  in  signiﬁcant  morbidity  and  mortality
18—21]. It  is  common  knowledge  that  anticoagulant  ther-
py  can  reduce  thromboembolic  risk  in  patients  with  AF  [22].
owever,  a  large  proportion  of  patients  with  AF,  who  will  not
evelop  thromboembolism  may  be  exposed  to  the  risks  asso-
iated  with  warfarin  therapy  [23]. On  the  other  hand,  some
atients  with  AF  who  have  already  had  warfarin  therapy  suf-
ered  from  cerebral  embolism  because  of  insufﬁciency  of
he  effect  of  warfarin.  The  CHADS2  score  was  proposed  as
 method  for  thromboembolic  risk  stratiﬁcation  in  routine
linical  practice  [13]. However,  current  risk  stratiﬁcation
chemes  used  to  predict  thromboembolism  in  patients  with
onvalvular  AF  have  similar  discriminatory  ability,  but  the
redictive  ability  is  relatively  poor  [24,25].  Promising  risk
tratiﬁcation  is  crucially  needed  to  improve  selection  of  AF
atients  who  require  strict  anticoagulant  therapy  [26].
Thrombotic  material  associated  with  AF  arises  most
requently  in  the  LAA.  Thrombus  formation  begins  with
irchow’s  triad  of  stasis,  endothelial  dysfunction,  and  a
ypercoagulable  state.  TEE  has  been  thought  to  be  a  sen-
itive  and  speciﬁc  method  to  assess  LAA  function  and  detect
hrombus  formation  [9,10,16,27]. We  validated  the  VVI
ethod  for  the  quantiﬁcation  of  LAAEF  and  LAEF  and  estab-
ished  the  value  of  these  parameters  for  LAA  thrombus  using
VI.
elocity  vector  imaging  for  the  detection  of  LAA
hrombus
urrently,  regional  myocardial  function  of  the  LA  and  LAA
n  AF  has  been  assessed  by  strain  rate  imaging  and  tis-
ue  Doppler  [28,29]. It  was  reported  that  the  mean  LAAEF
percent  area  change)  in  11  AF  patients  without  thrombus
as  18%,  and  also  reported  that  the  percent  area  change
uring  a  cardiac  cycle  of  LAA  in  AF  patients  was  reduced
ompared  with  those  in  sinus  rhythm  [29]. LAA  contractile
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Table  1  Patient  clinical  characteristics.
Number  AF  without  LAA  thrombus  (n  =  104)  AF  with  LAA  thrombus  (n  =  38)  p-value
Age  (year)  64.7  ±  11.6  69.1  ±  9.9  0.004
Male, n  (%)  80  (77)  30  (79)  0.80
Smoking, n  (%)  33  (34)  13  (34)  0.87
Diabetes mellitus,  n  (%)  18  (18)  10  (26)  0.29
Hypertension,  n  (%)  51  (49)  23  (61)  0.22
Prior stroke,  n  (%)  4  (4)  10  (26)  <0.001
AF duration,  n  (year) 5.4  ±  6.1  8.4  ±  7.3  0.015
Warfarin therapy,  n  (%) 89  (86) 34  (89)  0.54
CHADS2 score 0.97  ± 1.02  1.68  ± 1.45  0.011
PT-INR* 2.0  ± 0.4  2.0  ± 0.4  >0.99
Age, AF duration, and PT-INR are expressed as the mean ± one standard deviation. AF, atrial ﬁbrillation; LAA, left atrial appendage;
PT-INR, prothrombin-international normalized ratio.
* Including patients who did not take warfarin.
Table  2  Echocardiographic  parameters.
Number AF  without  LAA  thrombus  (n  =  104) AF  with  LAA  thrombus  (n  =  38)  p-value
LVEF  (%)  56.6  ±  9.7  52.4  ±  7.0  0.004
LAD (mm)  47.4  ±  8.0  51.9  ±  7.7  0.015
Max LAV  (mL) 121.7  ±  48.1  134.4  ±  52.4  0.17
LAEF (%) 27.0 ±  8.0  18.4  ±  4.3  <0.001
SEC score  (0—4  grade)  1.2  ±  0.8  1.8  ±  1.0  <0.001
LAAPV (cm/s) 29.9 ±  12.4  20.4  ±  8.0  <0.001
LAAMV (cm/s) 23.7 ±  9.6  14.4 ±  6.5  <0.001
LAAEF (%) 29.0 ±  9.7  16.9  ±  3.1  <0.001
Numerical data are expressed as the mean ± one standard deviation. AF, atrial ﬁbrillation; LAA, left atrial appendage; LAD, left atrial
dimension; Max LAV, maximum left atrial volume; LVEF, left ventricular ejection fraction; LAEF, left atrial emptying fraction; SEC,
spontaneous echo contrast; LAAPV, left atrial appendage peak velocity; LAAMV, left atrial appendage mean velocity; LAAEF, left atrial
appendage emptying fraction.
Figure  2  Comparison  between  manual-tracing  and  velocity  vector  imaging  (VVI)  method.  Left:  comparison  of  the  left  atrial
appendage emptying  fraction  (LAAEF)  and  left  atrium  emptying  fraction  (LAEF)  between  VVI  and  the  manual-tracing  method  in
atrial ﬁbrillation.  Right:  Bland  and  Altman  plot.
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Table  3  Multivariate  logistic  regression  analysis  for  LAA  thrombus.
Variables Odds  ratio  95%  conﬁdence  interval  p-value
Clinical  parameters
Age  1.049  0.971—1.121  0.21
Prior stroke  21.14  1.187—376.5  0.038
CHADS2 Score  1.332  0.829—2.140  0.24
AF duration 1.004  0.920—1.096  0.61
Echocardiographic  parameters
LVEF 0.966  0.895—1.042 0.37
LAD 1.042  0.964—1.127 0.30
LAEF 0.942  0.805—1.102  0.45
SEC score  2.303  1.040—5.098  0.040
LAAPV 0.998  0.923—1.076  0.96
LAAEF 0.631  0.499—0.800  <0.001
LAA, left atrial appendage; LAD, left atrial dimension; LVEF, left ventricular ejection fraction; LAEF, left atrial emptying fraction; SEC,
spontaneous echo contrast; LAAPV, left atrial appendage peak velocity; LAAEF, left atrial appendage emptying fraction.
Table  4  Accuracy  of  ultrasound  parameters  for  the  determinants  of  LAA  thrombus.
Cutoff  values  Sensitivity  Speciﬁcity  PPV  NPV
LAAEF  (≤20%)  92  (88—96)  88  (83—93)  74  (67—81)  97  (95—99)
SEC (≥grade  2)  53  (45—61)  72  (65—79)  41  (34—49)  81  (75—87)
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NPV, negative predictive value; LAAEF, left atrial appendage emp
unction,  like  LAA  emptying  fraction,  should  have  physio-
ogical  importance  in  thrombus  formation  as  well  as  ﬁlling
nd  emptying  dynamics.  However,  LAA  contractile  function
as  not  yet  been  elucidated  because  it  is  time-consuming
o  measure  LAAEF  by  the  manual-tracing  method  [9].  It
akes  less  than  one  minute  to  obtain  LAAEF  and  LAEF  by  VVI
ethod  but  more  than  twenty  minutes  by  manual  tracing
ethod.  In  the  present  study,  excellent  correlations  were
bserved  between  the  VVI  and  manual-tracing  methods  for
AA  and  LA  emptying  fraction.  The  parameters  measured
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igure  3  Receiver  operating  characteristic  curves  for  the  determ
ppendage emptying  fraction;  SEC,  spontaneous  echo  contrast;  AUCrvals. LAA, left atrial appendage; PPV, positive predictive value;
 fraction; SEC, spontaneous echo contrast.
y  VVI  were  signiﬁcantly  different  between  the  AF  patients
ith  and  without  LAA  thrombus.
tudy  limitationshere  are  several  limitations  in  the  present  study.  First,  LAA
olume  assessed  by  the  VVI  method  using  two-dimensional
EE  might  be  different  from  the  real  LAA  volume.  It  is
ot  always  easy  to  analyze  the  morphology  of  the  LAA  by
ination  of  left  atrial  appendage  thrombus.  LAAEF,  left  atrial
,  area  under  the  curve.
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two-dimensional  TEE,  because  it  was  reported  that  the  LAA
is  usually  a  multilobed  structure  in  an  autopsy  study  [30].
However,  three-dimensional  TEE  revealed  that  LAA  was  in
the  shape  of  a  round  in  a  living  body  [31]. In  addition,  we
measured  LAA  volume  by  two-dimensional  TEE  three  times
at  three  different  angles  from  70◦ to  90◦ and  used  aver-
age  values  for  further  analysis  to  improve  the  accuracy  of
the  LAA  volume  determined  by  VVI.  Furthermore,  we  deter-
mined  LAAEF  since  this  parameter  is  independent  of  the
absolute  LAA  volume.  Second,  our  ﬁndings  are  based  on
observations  in  a  relatively  small  number  of  patients,  par-
ticularly  in  the  patients  with  both  AF  and  thrombus.  Third,
we  cannot  draw  conclusions  regarding  long-term  outcomes,
because  the  present  study  was  a  cross-sectional  study  with-
out  any  additional  follow-up  of  patients.  A  prospective  study
in  a  larger  patient  population  on  long-term  outcomes  is
needed  to  elucidate  which  echocardiographic  parameter  is
the  most  useful  to  predict  LAA  thrombus.  The  predictive
accuracy  of  the  selected  cut-off  value  for  LAAEF  needs  to  be
tested  prospectively  in  an  independent  population  to  assess
its  clinical  value  to  predict  LAA  thrombosis.
Conclusions
The  VVI  method  was  accurate  and  reliable  in  the  measure-
ment  of  LAAEF  and  LAEF  compared  with  the  manual-tracing
method.  LAAEF  assessed  by  the  VVI  method  using  TEE  was  a
useful  determinant  of  LAA  thrombus.  AF  patients  with  LAAEF
less  than  20%  by  TEE  may  require  a  strict  regimen  of  warfarin
therapy  to  avoid  thromboembolic  events.
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